Deepak S. Nath, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,138 shares at $44.98 ($51K) on 2017-02-21, disclosed to the SEC on 2017-02-22.
Scheduled sale ($51k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.69 | 819 | $37K | 71.8% |
| 2 | $44.98 | 319 | $14K | 28.2% |
| Total | $44.77 avg | 1,138 | $51K | 100% |
| Filing → |
| ABT | SELL | 2016-03-02 | $31K | — | Filing → |
| ABT | SELL | 2016-02-23 | $12K | — | Filing → |
| ABT | SELL | 2016-02-17 | $6K | — | Filing → |